0.0400CAD+16.67%Mkt Cap: 5.92M CADP/E: —Last update: 2026-05-25
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap5.92M CAD
Enterprise Value6.86M CAD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.80M CAD
Revenue/Share—
Last Price0.0400 CAD
Fiscal Year EndJan 2025
MR QuarterOct 2025
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.26
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.030033% of range0.0600
52W High0.0600 CAD
52W Low0.0300 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-8.42%
ROA-7.98%
Growth
Revenue Growth—
Earnings Growth3010.20%
Cash Flow & Leverage
Operating CF-511.88K CAD
CapEx (TTM)—
FCF Margin—
FCF Yield-2.11%
Net Debt941.76K CAD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio0.07
Quick Ratio0.05
Book Value/Sh0.1360 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield67.86%
Payout Ratio0.00%
Ex-Div DateJul 21, 2005
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.169.13M
Float138.75M
Insiders16.88%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short5.24K
Short (prev mo.)61
Technical
SMA 500.0344 (+16.3%)
SMA 2000.0385 (+3.9%)
Beta-0.25
S&P 52W Chg28.31%
Avg Vol (30d)26.37K
Avg Vol (10d)27.78K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—